Comparisons of 3-month Versus 6-month Solifenacin Treatment for Female OAB Patients
NCT01876186
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
200
Enrollment
OTHER
Sponsor class
Conditions
Overactive Bladder Syndrome
Interventions
DRUG:
Solifenacin for 12 weeks
DRUG:
Solifenacin for 24 weeks
Sponsor
National Taiwan University Hospital